NCT06421753

Brief Summary

To determine whether Spatially Distributed Sequential Functional Electrical Stimulation is more effective than Standard Electrical Stimulation During Functional Electrical Stimulation in Upper Motor Neuron Patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 14, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

May 16, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 20, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

September 19, 2025

Status Verified

May 1, 2024

Enrollment Period

8 months

First QC Date

May 14, 2024

Last Update Submit

September 17, 2025

Conditions

Keywords

functional electrical stimulationmuscle fatiguerehabilitationspinal cord injurystrokemultiple sclerosis

Outcome Measures

Primary Outcomes (1)

  • Average quadriceps power output (watts) measured during 3 minutes of FES cycling

    The subjects are installed on a Hepha Bike electrostimulation bike, equipped with force-torque measuring pedals (ICS\_RM, Sensix, France), synchronized with a MotiMove-8 stimulator. The average quadriceps power (watts) during the first and last 30 seconds of each stimulation phase, as well as the total average power (Pm) are calculated.

    during sessions of FES cycling

Secondary Outcomes (1)

  • Evaluate the comfort of dry and hydrogel based functional electrical stimulation electrodes

    before the first session of FES cycling

Study Arms (2)

Spatially Distributed Sequential Functional Electrical Stimulation

EXPERIMENTAL

Interventions: 3 FES cycling sessions separated by 48h of rest. Each session is comprised of 2 phases separated by 20 minutes of rest. Each phase is comprised of a 3 minutes passive cycling warm-up, followed by 3 minutes of electrically stimulated cycling.

Device: SDSS

Standard Electrical Stimulation During Functional Electrical Stimulation

ACTIVE COMPARATOR

Each session begins with a 3-minute warm-up phase, followed by a 3-minute stimulation phase. The motor rotates the legs at 50 rpm during both phases. The type of stimulation used in the first phase is chosen randomly. After a 20-minute break, the second warm-up and stimulation phases are carried out. During the second session, the order of the stimulation phases is reversed.

Device: Standard Electrical Stimulation During Functional Electrical Stimulation

Interventions

SDSSDEVICE

Each session begins with a 3-minute warm-up phase, followed by a 3-minute stimulation phase. The motor rotates the legs at 50 rpm during both phases. The type of stimulation used in the first phase is chosen randomly. After a 20-minute break, the second warm-up and stimulation phases are carried out During the second session, the order of the stimulation phases is reversed.

Spatially Distributed Sequential Functional Electrical Stimulation

Each session begins with a 3-minute warm-up phase, followed by a 3-minute stimulation phase. The motor rotates the legs at 50 rpm during both phases. The type of stimulation used in the first phase is chosen randomly. After a 20-minute break, the second warm-up and stimulation phases are carried out During the second session, the order of the stimulation phases is reversed.

Standard Electrical Stimulation During Functional Electrical Stimulation

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with Upper Motor Neuron syndrome:
  • adult (\> 18 years)
  • motor deficit due to an acquired traumatic or neurodegenerative motor deficiency of the central nervous system (MRC\<4/5)
  • stable clinical condition, particularly on the cardiovascular level (recent assessment by a cardiologist with stress test)
  • non denervated muscles
  • tolerant to muscle electrical stimulation
  • having given written consent
  • able to cycle 30 minutes with FES-cycling

You may not qualify if:

  • major cognitive comprehension disorders that could compromise understanding of the protocol and the smooth running of the study
  • cardiac pacemaker and other contraindications relating to the use of electrostimulation (in particularly "deep vein thrombosis")
  • spasticity of the lower limbs making flexion/extension movement difficult
  • participation in another study
  • pregnancy
  • people with the following legal and administrative states or situations:
  • people placed under judicial protection;
  • persons deprived of their liberty, persons subject to psychiatric care and persons admitted to a health or social establishment for purposes other than that of clinical investigation;
  • unemancipated minors;
  • people who are not affiliated to a social security scheme or beneficiaries of such a scheme

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SMR Val Rosay

Saint-Didier-au-Mont-d'Or, France, 69370, France

Location

MeSH Terms

Conditions

Motor Neuron DiseaseSpinal Cord InjuriesStrokeMultiple Sclerosis

Condition Hierarchy (Ancestors)

Neurodegenerative DiseasesNervous System DiseasesNeuromuscular DiseasesSpinal Cord DiseasesCentral Nervous System DiseasesTrauma, Nervous SystemWounds and InjuriesCerebrovascular DisordersBrain DiseasesVascular DiseasesCardiovascular DiseasesDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: SCED : Single Case Experimental Design Each patient is his own control Patient will be randomised to receive FES-cycling with SDSS or standard electrical stimulation
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 14, 2024

First Posted

May 20, 2024

Study Start

May 16, 2024

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

September 19, 2025

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations